List of Tables
TABLE 1. BLOOD CANCER DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY STEM CELL TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY STEM CELL TRANSPLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY ACUTE LYMPHOBLASTIC LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY ACUTE LYMPHOBLASTIC LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY CHRONIC LYMPHOCYTIC LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY CHRONIC LYMPHOCYTIC LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY CHRONIC MYELOID LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY CHRONIC MYELOID LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY HODGKIN LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY HODGKIN LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY NON-HODGKIN LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY NON-HODGKIN LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY THIRD LINE AND LATER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY THIRD LINE AND LATER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY MYELODYSPLASTIC SYNDROMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY MYELODYSPLASTIC SYNDROMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BLOOD CANCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BLOOD CANCER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BLOOD CANCER DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 114. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 115. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 118. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 119. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 120. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 121. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 122. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 123. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 134. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 135. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 136. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 137. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 138. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 139. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. MEXICO BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 216. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 217. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 218. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 219. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 220. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 221. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. GERMANY BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 232. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 233. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 234. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 235. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 236. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 237. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. FRANCE BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 260. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 261. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 264. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 265. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 266. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 267. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 268. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 269. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. ITALY BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 280. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 281. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 282. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 283. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 284. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 285. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. SPAIN BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. SAUDI ARABIA BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 330. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2018-2024 (USD MILLION)
TABLE 332. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY MULTIPLE MYELOMA, 2025-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 334. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA BLOOD CANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)